Skip to main content
OpenTrials

Clinical trial condition

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

Explore clinical trials studying Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer trial results

Recruiting

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

NCT06065748

Conditions
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Locations
  • Southern Cancer Center Daphne, Alabama, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • La Hematology Oncology Medical Group Glendale, California, United States
  • Marin Cancer Care Inc Greenbrae, California, United States
View all 352 locations
View Trial Details